Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Nadkarni

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemiaS Karfa, R Gopal, J S Nadkarni
Journal of Neuro-Oncology|February 1, 1996
Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumorsS K Sankhla, J S Nadkarni, S N Bhagwati
Journal of Cancer Research and Clinical Oncology|January 1, 1993
A specific and rapid receptor assay for squamous-cell carcinoma of human esophagusG T Panse, J S Nadkarni, J J Nadkarni
Hematological Oncology|July 22, 1999
Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosisM Anand, S K Chodda, P M Parikh, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Dysregulated cytokine production by monocytes from chronic lymphocytic leukemia patientsM Anand, S K Chodda, P M Parikh, et al.
Neoplasma|January 1, 1981
Immune status in untreated cervical cancer patientsM N Satam, J J Nadkarni, J S Nadkarni, et al.
Hybridoma|April 1, 1988
Unique monoclonal antibodies against soluble membrane proteins of human CML myelocytes reactive with human myeloid progenitor cellsJ S Nadkarni, L S Nadkarni, S H Advani, et al.
Neoplasma|January 1, 1994
Characterization of a pan-lymphocyte monoclonal antibody useful in differentiating leukemic from normal myeloid progenitors and monocytes from macrophagesJ S Nadkarni, V S Chitnis, G T Panse, et al.
Cancer Investigation|January 1, 1996
Tumor necrosis factor as marker for monocyte function in chronic myeloid leukemiaV S Chitnis, P M Parikh, J S Nadkarni, et al.
Tumori|December 23, 1998
Characterization of a murine monoclonal antibody against human esophageal squamous cell carcinoma-associated antigenJ S Nadkarni, P R Bhadsavle, V S Chitnis, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemiaS Karfa, R Gopal, J S Nadkarni
Journal of Neuro-Oncology|February 1, 1996
Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumorsS K Sankhla, J S Nadkarni, S N Bhagwati
Journal of Cancer Research and Clinical Oncology|January 1, 1993
A specific and rapid receptor assay for squamous-cell carcinoma of human esophagusG T Panse, J S Nadkarni, J J Nadkarni
Hematological Oncology|July 22, 1999
Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosisM Anand, S K Chodda, P M Parikh, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Dysregulated cytokine production by monocytes from chronic lymphocytic leukemia patientsM Anand, S K Chodda, P M Parikh, et al.
Neoplasma|January 1, 1981
Immune status in untreated cervical cancer patientsM N Satam, J J Nadkarni, J S Nadkarni, et al.
Hybridoma|April 1, 1988
Unique monoclonal antibodies against soluble membrane proteins of human CML myelocytes reactive with human myeloid progenitor cellsJ S Nadkarni, L S Nadkarni, S H Advani, et al.
Neoplasma|January 1, 1994
Characterization of a pan-lymphocyte monoclonal antibody useful in differentiating leukemic from normal myeloid progenitors and monocytes from macrophagesJ S Nadkarni, V S Chitnis, G T Panse, et al.
Cancer Investigation|January 1, 1996
Tumor necrosis factor as marker for monocyte function in chronic myeloid leukemiaV S Chitnis, P M Parikh, J S Nadkarni, et al.
Tumori|December 23, 1998
Characterization of a murine monoclonal antibody against human esophageal squamous cell carcinoma-associated antigenJ S Nadkarni, P R Bhadsavle, V S Chitnis, et al.
Pageof 2